SORIA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 2.972
EU - Europa 1.760
AS - Asia 765
SA - Sud America 138
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 5.655
Nazione #
US - Stati Uniti d'America 2.925
IT - Italia 389
SG - Singapore 354
DE - Germania 320
RU - Federazione Russa 287
SE - Svezia 253
IE - Irlanda 203
CN - Cina 147
BR - Brasile 108
HK - Hong Kong 108
GB - Regno Unito 66
UA - Ucraina 61
ID - Indonesia 43
CA - Canada 41
AT - Austria 40
IN - India 38
DK - Danimarca 30
FI - Finlandia 26
VN - Vietnam 23
FR - Francia 22
TR - Turchia 20
NL - Olanda 17
CO - Colombia 14
BE - Belgio 13
AR - Argentina 7
IR - Iran 7
CZ - Repubblica Ceca 6
PL - Polonia 5
CL - Cile 4
EU - Europa 4
GR - Grecia 4
JP - Giappone 4
BG - Bulgaria 3
CH - Svizzera 3
IQ - Iraq 3
KE - Kenya 3
PH - Filippine 3
PK - Pakistan 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
EC - Ecuador 2
ES - Italia 2
LT - Lituania 2
MX - Messico 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.655
Città #
Ann Arbor 894
Frankfurt am Main 245
Chandler 244
Fairfield 225
Singapore 221
Dublin 200
Wilmington 146
Ashburn 126
New York 118
Woodbridge 111
Hong Kong 108
Houston 107
Seattle 86
Milan 76
Cambridge 70
Princeton 70
Santa Clara 63
Jacksonville 48
Jakarta 43
Altamura 37
Dearborn 36
Lawrence 32
Vienna 30
Shanghai 26
Guangzhou 19
Nanjing 19
Pune 19
London 18
Andover 17
Fremont 17
Boardman 15
Dong Ket 14
Rome 14
Moscow 13
Ottawa 13
Brussels 12
Helsinki 12
Nuremberg 12
San Diego 12
Los Angeles 11
Bogotá 10
Council Bluffs 9
Lachine 9
Falls Church 8
Shenyang 8
São Paulo 8
Busto Arsizio 7
Changsha 7
Hebei 7
Lissone 7
Monza 7
Toronto 7
Florence 6
Nanchang 6
Amsterdam 5
Beijing 5
Bresso 5
Brno 5
Dallas 5
Edmonton 5
Jinan 5
Kiev 5
Palermo 5
Peschiera Borromeo 5
Rovereto 5
Turin 5
Washington 5
Brescia 4
Enterprise 4
Konya 4
Munich 4
Ningbo 4
Paris 4
Polska 4
Stockholm 4
Athens 3
Carate Brianza 3
Catania 3
Chicago 3
Guarulhos 3
Hangzhou 3
Hanoi 3
Kocaeli 3
Lappeenranta 3
Maastricht 3
Melzo 3
Nairobi 3
North York 3
Romola 3
Santiago 3
Shenzhen 3
Sofia 3
Taizhou 3
Tokyo 3
Weimar 3
Albano Sant'Alessandro 2
Altamonte Springs 2
Auckland 2
Baku 2
Bangalore 2
Totale 3.872
Nome #
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 372
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 248
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 246
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 243
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 230
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 225
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 222
HIV testing: A must for patients with inflammatory bowel disease 215
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 213
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 200
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 193
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 189
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 187
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 185
High rates of 30-day mortality in patients with cirrhosis and COVID-19 185
Unmasking tuberculosis in the era of antiretroviral treatment 178
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 173
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 172
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 170
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 145
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 135
Beware of biases in observational studies on anti-spike monoclonal antibodies 126
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 119
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 119
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 119
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 103
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 101
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 86
Pharmacotherapy of HIV: Focus on Etravirine 80
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 79
Imported ciprofloxacin-resistant Neisseria meningitidis 74
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 70
Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals 70
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 63
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 59
Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests 58
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study 57
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 55
COVID-19 Infection among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021 49
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition 48
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 34
Reply 18
Reply 12
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 5.928
Categoria #
all - tutte 23.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.482


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020143 0 0 0 0 0 0 0 0 0 47 53 43
2020/20211.042 37 49 70 120 120 90 73 100 93 109 63 118
2021/2022777 89 95 125 80 33 73 8 33 18 59 60 104
2022/20231.042 107 310 106 97 52 151 17 74 63 9 38 18
2023/2024711 26 18 30 24 100 222 126 34 36 19 8 68
2024/20251.346 84 189 128 79 155 92 141 66 154 258 0 0
Totale 5.928